IMPORTANT - EIN Presswire is proud to announce the launch of its AI-powered press release generator. Try it now!

IMPORTANT - EIN Presswire is proud to announce the launch of its AI-powered press release generator. Try it now!

World Media Directory · RSS · Email Newsletters

There were 88 press releases posted in the last 24 hours and 401,075 in the last 365 days.

Press Releases on March 14, 2023

2,567 Press Releases

Published on March 14, 2023 - 20:31 GMT

Erasca Announces Poster Presentation at the 2023 AACR Annual Meeting

SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today …

Distribution channels: Culture, Society & Lifestyle, Technology ...
Published on March 14, 2023 - 20:30 GMT

New Romantic Dramedy, "Mother In Law," Showcases Black Love, Caught in the Family Ties That Bind

“Mother in Law” Stars Powerhouse Names from Hollywood and Nollywood LOS ANGELES, CALIFORNIA, USA, March 14, 2023 /⁨EINPresswire.com⁩/ -- The indie, “Mother in Law,” starring powerhouse names from Hollywood and Nollywood is set to make its world premiere …

Distribution channels: Culture, Society & Lifestyle, Movie Industry ...
Published on March 14, 2023 - 20:30 GMT

Evaxion Biotech to announce clinical data for the personalized DNA cancer vaccine EVX-02 at the 2023 American Association for ...

COPENHAGEN, Denmark, March 14, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-powered immunotherapies, today announced that the company …

Distribution channels: Technology
Published on March 14, 2023 - 20:30 GMT

Immunocore to present four posters at AACR Annual Meeting 2023

Immunocore to present four posters at AACR Annual Meeting 2023 Updated three-year overall survival data for tebentafusp-tebn in previously treated metastatic uveal melanoma Phase 3 data showing early ctDNA reduction on tebentafusp-tebn associated with …

Distribution channels: Technology
Published on March 14, 2023 - 20:30 GMT

Pyxis Tankers Announces Date for the Release of the Fourth Quarter and Year Ended 2022 Results and Related Conference Call & ...

Maroussi, Greece, March 14, 2023 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international pure-play product tanker company, today announced the following: Date of Earnings Release. We will issue our unaudited results for the fourth quarter and year …

Distribution channels: Media, Advertising & PR, Shipping, Storage & Logistics ...
Published on March 14, 2023 - 20:30 GMT

ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting

ORIC-944 preclinical poster presentation to highlight comprehensive biomarker strategy for ongoing Phase 1 trial in metastatic prostate cancer PLK4 poster presentation to spotlight the high selectivity required for synthetic lethality in breast cancer …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on March 14, 2023 - 20:30 GMT

Nitrase Therapeutics to Present at the 2023 American Association for Cancer Research Annual Meeting

BRISBANE, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Nitrase Therapeutics, Inc., a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, a new class of enzymes discovered in-house that are involved in …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 14, 2023 - 20:30 GMT

Advantage Solutions Names New Chief Financial Officer, Chief Human Resources Officer and Chief Communications Officer

IRVINE, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage” or the “Company”), a leading provider of outsourced sales and marketing services to consumer goods manufacturers and retailers, today announced the hires …

Distribution channels:
Published on March 14, 2023 - 20:30 GMT

Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders 44th Annual Meeting and the American ...

SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present a quantitative systems pharmacology (QSP) model for predicting the effects of the investigational enzyme replacement …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 14, 2023 - 20:30 GMT

23andMe Announces Presentation of Phase 1 Clinical Data for 23ME-00610, an Investigational Antibody Targeting CD200R1, at the ...

SOUTH SAN FRANCISCO, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe) announced that clinical data from the Phase 1 portion of the Phase 1/2a study of 23ME-00610 has been selected for a poster presentation at the …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 14, 2023 - 20:30 GMT

Bellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic Alternatives

HOUSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), today announced its decision to discontinue its ongoing Phase 1/2 clinical trials evaluating the safety and preliminary efficacy of its GoCAR-T cell product …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on March 14, 2023 - 20:30 GMT

Bolt Biotherapeutics to Present Preclinical Data for BDC-3042, a Dectin-2-Targeting Agonistic Antibody, at 2023 AACR Annual ...

REDWOOD CITY, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immuno-oncology therapeutics for the treatment of cancer, today announced that it will present a …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 14, 2023 - 20:30 GMT

Alpine Acquisition Corporation Announces Intention to Further Adjourn Special Meeting of Stockholders

Expected to Reconvene March 28, 2023 at 12:00 p.m. Eastern Time FOUNTAIN HILLS, ARIZONA, March 14, 2023 (GLOBE NEWSWIRE) -- Alpine Acquisition Corporation (“Alpine” or the “Company”) (Nasdaq: REVE) announced today that it intends to further adjourn its …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR
Published on March 14, 2023 - 20:30 GMT

Tempest to Present New Translational and Preclinical Data at the 2023 AACR Annual Meeting

BRISBANE, Calif., March 14, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted and immune-mediated mechanisms, today announced that two …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 14, 2023 - 20:30 GMT

Immuneering to Present Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2023

Demonstrates ability to identify patient populations that may benefit from IMM-1-104 treatment Biomarker discovery and clinical translation supports patient selection in ongoing Phase 1/2a clinical trial with IMM-1-104 in patients with advanced solid …

Distribution channels: Culture, Society & Lifestyle, Technology ...
Published on March 14, 2023 - 20:30 GMT

Merus Announces Petosemtamab in Previously Treated Head and Neck Squamous Cell Carcinoma Abstract Selected for Plenary Session ...

– Plenary session oral presentation: Monday, April 17, 2023, 10:15 a.m.-12:15 p.m. ET – Poster presentation on petosemtamab in advanced gastric/esophageal adenocarcinoma: Monday, April 17, 2023, 1:30-5:30 p.m. ET – Investor call on Monday, April 17, 2023 …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 14, 2023 - 20:30 GMT

Merus Announces Publication of an Abstract on Preclinical Mechanism of Action of MCLA-129 Selected for Poster Presentation at the ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., March 14, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on March 14, 2023 - 20:30 GMT

Globalink Investment Inc. Announces Termination of Merger Agreement

New York, NY, March 14, 2023 (GLOBE NEWSWIRE) -- Globalink Investment Inc. (Nasdaq: GLLI, GLLIW, GLLIR, GLLIU) (“Globalink”), a special purpose acquisition company, announced today that the previously announced agreement and plan of merger (the “Merger …

Distribution channels: Banking, Finance & Investment Industry
Published on March 14, 2023 - 20:30 GMT

Integrated Wellness Acquisition Corp Confirms Funding and Extension of Deadline to Complete Business Combination

New York, March 14, 2023 (GLOBE NEWSWIRE) -- Integrated Wellness Acquisition Corp (NYSE: WEL) (the “Company”) announced today that its sponsor, IWH Sponsor LP (the “Sponsor”), has deposited an aggregate of $1.15 million (representing $0.10 per public share …

Distribution channels: Environment, Retail ...
Published on March 14, 2023 - 20:30 GMT

Affimed Announces Presentations of Clinical Data from AFM13 Phase 2 REDIRECT and Pre-clinical Data Demonstrating CD16A Shedding ...

An oral presentation on the safety and efficacy from the AFM13 phase 2 monotherapy clinical study (“REDIRECT”) in patients with CD30-positive relapsed or refractory (R/R) peripheral T-cell lymphoma (PTCL) A poster presentation from the collaboration with …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Previous 12 13 14 15 16 17 18 19 20 21 22 Next

Previous Day 2023 Calendar Next Day